Pathogen News and Research

RSS

Compounds used to fight fungal diseases in plants may be driving antimicrobial resistance

New research from the University of Georgia has shown, for the first time, that compounds used to fight fungal diseases in plants are causing resistance to antifungal medications used to treat people.

8 Feb 2022

Antibody drug improves survival rates in canine prostate cancer model

Dogs are proving to be a far better scientific model for study of prostate cancer than mice, the typical animal used in the lab for this type of research.

8 Feb 2022

PCR data sheds light on the dynamics of interspecies pathogen-pathogen interactions

The new study uses PCR data on 17 different pathogens, collected from clinical samples as part of the Seattle Flu Study, a community-based surveillance study of respiratory viral infections.

8 Feb 2022

Thermo Fisher Scientific launches rapid environmental PCR testing solution that detects in-air SARS-CoV-2 pathogens

Thermo Fisher Scientific Inc. today announced the launch of a new rapid environmental test to help in the fight against COVID-19. The Thermo Scientific Renvo Rapid PCR Test is the latest solution in the company’s in-air pathogen surveillance product portfolio. The Renvo Rapid PCR Test is performed on air samples collected using the company’s Thermo Scientific AerosolSense Sampler.

From Thermo Scientific™ AerosolSense™ Sampler 8 Feb 2022

Innate immune processes involved in SARS-CoV-2 recognition and resultant inflammation

A new article reviewed the innate immune detection and signaling pathways that the host uses against SARS-CoV-2.

7 Feb 2022

Northwestern researchers study COVID-19 mechanisms, infection patterns and impact on gender minorities

Northwestern Medicine investigators continue to study the COVID-19 pandemic, from the biological mechanisms of disease and infection patterns to the pandemic's impact on women and sexual and gender minorities.

6 Feb 2022

Cognitive shortcuts may promote unsafe behaviors during the COVID-19 pandemic

If close friends and family members who contracted COVID-19 had mild cases and recovered quickly, or if they had an adverse reaction to the vaccine, your brain might convince you that you'd have the same experience.

4 Feb 2022

Study assesses how vaccination against typhoid fever could help avert antimicrobial resistance

Researchers from Yale University, University of Basel, University of Antwerp, CDDEP and other institutions recently published 'Estimating the effect of vaccination on antimicrobial-resistant typhoid fever in 73 countries supported by Gavi: a mathematical modeling study' in The Lancet Infectious Diseases.

4 Feb 2022

Wistar researchers takes a promising step in the direction of developing HIV vaccine

Nearly four decades after its discovery, HIV has killed 36.3 million people, with no vaccine in sight. However, a new study by researchers at The Wistar Institute, an international biomedical research leader in cancer, immunology, infectious disease, and vaccine development, takes a promising step in the direction of developing an HIV vaccine.

4 Feb 2022

Global efforts to track COVID-19 variants grossly underreported a probable variant of concern in Nigeria

If the United States ignores COVID-19 in Nigeria, we forgo global genomic surveillance at our own peril, reports a new Northwestern Medicine study published in Nature Communications.

3 Feb 2022

NIAID's new pandemic preparedness efforts aim to characterize prototype and priority pathogens

As the global COVID-19 pandemic continues into its third year, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is focusing on preparing for a range of other viral threats that could cause a public health emergency.

2 Feb 2022

Study finds disparities in COVID-19 vaccine hesitancy and uptake among racial, ethnic minorities

People from racial and ethnic minorities in the United States and the United Kingdom were up to three times as likely to report being unsure or unwilling to get a COVID-19 vaccine during the initial vaccine rollout compared to white participants, found a study published in Nature Communications.

1 Feb 2022

New blood test quickly detects COVID-19 infection and disease severity

George Washington University researchers have developed a blood test that quickly detects if someone has COVID-19 and predicts how severely the immune system will react to the infection, according to a new study coming out today in PLOS One.

1 Feb 2022

Estimating the impending endemic seasonality of SARS-CoV-2 in global population centers

A new study uses long-term data on the incidence of circulating coronaviruses and estimates the endemic seasonality of SARS-CoV-2 in global population centers.

31 Jan 2022

Binding and conformational properties of the SARS-CoV spike protein and hACE2 complex

A new paper in the journal Molecules describes this in molecular terms, comparing SARS-CoV-2 with an earlier highly pathogenic coronavirus, SARS-CoV.

31 Jan 2022

A substrate envelope approach to examine drug resistance potential of SARS-CoV-2 Mpro

A team of scientists from the United States has recently defined the substrate envelop of the main protease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The study is currently available on the bioRxiv* preprint server while awaiting peer review.

31 Jan 2022

Parasite present in seawater will help to explain how multicellularity developed in animals

Researchers from the UPV/EHU-University of the Basque Country and CEFAS have discovered a parasite present in seawater and which belongs to a primitive lineage; they have named it Txikispora philomaios.

29 Jan 2022

Study reveals role of a protein in healthy functioning of blood stem cells

A protein that masterminds the way DNA is wrapped within chromosomes has a major role in the healthy functioning of blood stem cells, which produce all blood cells in the body, according to a new study from researchers at Weill Cornell Medicine.

28 Jan 2022

Exploring receptor-blocking conserved non-neutralizing antibodies for SARS-CoV-2 therapy

In a new study, researchers hypothesized and developed broad-spectrum SARS-CoV-2 inhibitors, ReconnAbs, by modifying the existing non-neutralizing antibodies targeted towards the highly conserved epitopes of the SARS-CoV-2 spike (S) protein combined with a receptor-blocking component.

28 Jan 2022

England returns to Plan A following the success of booster rollout and falling Omicron infections

From 00:01 on Thursday 27th January England returned to Plan A measures following the huge success of the vaccination program and falling Omicron infections.

26 Jan 2022

Pathogen News and Research

Compounds used to fight fungal diseases in plants may be driving antimicrobial resistance

Antibody drug improves survival rates in canine prostate cancer model

PCR data sheds light on the dynamics of interspecies pathogen-pathogen interactions

Thermo Fisher Scientific launches rapid environmental PCR testing solution that detects in-air SARS-CoV-2 pathogens

Innate immune processes involved in SARS-CoV-2 recognition and resultant inflammation

Northwestern researchers study COVID-19 mechanisms, infection patterns and impact on gender minorities

Cognitive shortcuts may promote unsafe behaviors during the COVID-19 pandemic

Study assesses how vaccination against typhoid fever could help avert antimicrobial resistance

Wistar researchers takes a promising step in the direction of developing HIV vaccine

Global efforts to track COVID-19 variants grossly underreported a probable variant of concern in Nigeria

NIAID's new pandemic preparedness efforts aim to characterize prototype and priority pathogens

Study finds disparities in COVID-19 vaccine hesitancy and uptake among racial, ethnic minorities

New blood test quickly detects COVID-19 infection and disease severity

Estimating the impending endemic seasonality of SARS-CoV-2 in global population centers

Binding and conformational properties of the SARS-CoV spike protein and hACE2 complex

A substrate envelope approach to examine drug resistance potential of SARS-CoV-2 Mpro

Parasite present in seawater will help to explain how multicellularity developed in animals

Study reveals role of a protein in healthy functioning of blood stem cells

Exploring receptor-blocking conserved non-neutralizing antibodies for SARS-CoV-2 therapy

England returns to Plan A following the success of booster rollout and falling Omicron infections

Best practices - optimize qPCR processes for pathogen detection eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics